The Utilization of Oocyte Cryopreservation Among Indonesia Women


  • Batara Sirait Department of Obstetrics and Gynaecology, Faculty of Medicine Universitas Kristen Indonesia, Jakarta, Indonesia
  • Nining Handayani IRSI Research and Training Center, Jakarta, Indonesia
  • Ayu Mulia Sundari IRSI Research and Training Center, Jakarta, Indonesia
  • Tri Aprilliana Wulandari IRSI Research and Training Center, Jakarta, Indonesia
  • Ivan Sini IRSI Research and Training Center, Jakarta, Indonesia
  • Arie Adrianus Polim IRSI Research and Training Center, Jakarta, Indonesia
  • Muhammad Rizal Morula IVF Jakarta Clinic, Jakarta, Indonesia
  • Arief Boediono IRSI Research and Training Center, Jakarta, Indonesia



fertility preservation, oocyte cryopreservation, oocyte vitrification


Our study aims to assess the utilization of oocyte cryopreservation (OC) in Indonesian women. Data from 122 women who had undergone OC was retrospectively analyzed from medical records. The baseline profile, clinical characteristics, and main outcomes comprising intentions for oocyte vitrification and outcomes following oocyte warming were examined. Out of 122 women who underwent OC, 49 patients returned and use their cryopreserved oocytes with a median duration of storage was two months. Arranged from the greatest to the least, participants had undergone the cycle of OC due to sperm factor [51 (41.80%)], increased embryo availability [6 (12.1%)], postponement of marriage [6 (12.1%)], social reasons [10 (8.19%)], and other reasons [8 (6.55%)]. Meanwhile, treatment due to advanced maternal age [6 (4.91%)], poor ovarian reserve [6 (4.91%)], cancer [5 (4.09%)], PCOS [2 (1.63%)], and endometriosis [2 (1.63%)] was reported among remaining subjects. Clinical pregnancy was reported in 12 (40.0%) patients constituting of each 6 (50.0%) subjects of day-3 and day-5 embryo transfer, respectively. Our study demonstrated that sperm factor, increased embryo availability, and postponement of marriage is the main reason for women undergoing OC in Indonesia. 


Cil AP, Seli E. Current trends and progress in clinical applications of oocyte cryopreservation. Curr Opin Obstet Gynecol [Internet]. 2013 Jun [cited 2022 Jun 3];25(3):247–54. Available from: /pmc/articles/PMC3869229/

Jang TH, Park SC, Yang JH, Kim JY, Seok JH, Park US, et al. Cryopreservation and its clinical applications. Integr Med Res [Internet]. 2017 Mar [cited 2022 Jun 3];6(1):12. Available from: /pmc/articles/PMC5395684/

Rienzi L, Gracia C, Maggiulli R, Labarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update [Internet]. 2017 Mar 1 [cited 2022 Jun 3];23(2):139. Available from: /pmc/articles/PMC5850862/

Bagchi A, Woods EJ, Critser JK. Cryopreservation and vitrification: Recent advances in fertility preservation technologies. Expert Rev Med Devices. 2008;5(3):359–70.

Johnston M, Richings NM, Leung A, Sakkas D, Catt S. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Hum Reprod [Internet]. 2021 Mar 1 [cited 2022 Jun 3];36(3):624–35. Available from:

Dondorp WJ, De Wert GMWR. Fertility preservation for healthy women: ethical aspects. Hum Reprod [Internet]. 2009 [cited 2022 Jun 8];24(8):1779–85. Available from:

Roberts J, Ronn R, Tallon N, Holzer H. Fertility preservation in reproductive-age women facing gonadotoxic treatments. Curr Oncol [Internet]. 2015 Aug 20 [cited 2022 Jun 9];22(4):e294. Available from: /pmc/articles/PMC4530827/

Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online [Internet]. 2011 Sep [cited 2022 Jun 9];23(3):323–33. Available from:

Salama M, Woodruff TK. Anticancer Treatments and Female Fertility: Clinical Concerns and Role of Oncologists in Oncofertility Practice. Expert Rev Anticancer Ther [Internet]. 2017 Aug 3 [cited 2022 Jun 9];17(8):687. Available from: /pmc/articles/PMC6145143/

Lin PY, Huang CC, Chen HH, Huang BX, Lee MS. Failed sperm retrieval from severely oligospermic or non-obstructive azoospermic patients on oocyte retrieval day: Emergent oocyte cryopreservation is a feasible strategy. PLoS One [Internet]. 2019 Nov 1 [cited 2022 Jun 15];14(11). Available from: /pmc/articles/PMC6860430/

Baldwin K, Culley L, Hudson N, Mitchell H, Lavery S. Oocyte cryopreservation for social reasons: demographic profile and disposal intentions of UK users. Reprod Biomed Online [Internet]. 2015 Aug 1 [cited 2022 Jun 17];31(2):239–45. Available from:

Inhorn MC, Birenbaum-Carmeli D, Birger J, Westphal LM, Doyle J, Gleicher N, et al. Elective egg freezing and its underlying socio-demography: A binational analysis with global implications. Reprod Biol Endocrinol [Internet]. 2018 Jul 23 [cited 2022 Jun 17];16(1):1–11. Available from:

Ben-Nagi J, Kasaven LS, Jones BP, Saso S, Norris G, Green J, et al. Oocyte yield in social, medical and donor oocyte cryopreservation cycles. Hum Fertil (Camb) [Internet]. 2020 [cited 2022 Jun 17]; Available from:

Kasaven L, Jones B, Heath C, Odia R, Green J, Petrie A, et al. Analysis of ten years of social oocyte cryopreservation: a research article. Authorea Prepr [Internet]. 2020 Oct 9 [cited 2022 Jun 17]; Available from:

Goldman RH, Racowsky C, Farland L V., Munné S, Ribustello L, Fox JH. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod [Internet]. 2017 Apr 1 [cited 2022 Jun 17];32(4):853–9. Available from:

Mahesan AM, Sadek S, Ramadan H, Bocca S, Paul ABM, Stadtmauer L. Knowledge and attitudes regarding elective oocyte cryopreservation in undergraduate and medical students. Fertil Res Pract 2019 51 [Internet]. 2019 Apr 10 [cited 2022 Jun 17];5(1):1–7. Available from:

Chronopoulou E, Raperport C, Sfakianakis A, Srivastava G, Homburg R. Elective oocyte cryopreservation for age-related fertility decline. J Assist Reprod Genet [Internet]. 2021 May 1 [cited 2022 Nov 14];38(5):1177. Available from: /pmc/articles/PMC7894970/

Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril [Internet]. 2015 Jun 1 [cited 2022 Nov 14];103(6):1551-1556.e4. Available from:

Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod [Internet]. 2011 Jul 1 [cited 2022 Nov 14];26(7):1768–74. Available from:

Ehiabhi Okohue J, Ikimaloc JI, Onuh SO. Ejaculation failure on the day of oocyte retrieval for IVF: A report of five cases. Middle East Fertil Soc J. 2011 Jun 1;16(2):159–62.

Richardson D, Goldmeier D, Dysfunction BSIG for S. Recommendations for the management of retarded ejaculation: BASHH Special Interest Group for Sexual Dysfunction. [Internet]. 2016 Jun 25 [cited 2022 Nov 14];17(1):7–13. Available from:

Lin PY, Huang CC, Chen HH, Huang BX, Lee MS. Failed sperm retrieval from severely oligospermic or non-obstructive azoospermic patients on oocyte retrieval day: Emergent oocyte cryopreservation is a feasible strategy. PLoS One [Internet]. 2019 Nov 1 [cited 2022 Nov 14];14(11):e0224919. Available from:

Virant-Klun I, Bacer-Kermavner L, Tomazevic T, Vrtacnik-Bokal E. Slow oocyte freezing and thawing in couples with no sperm or an insufficient number of sperm on the day of in vitro fertilization. Reprod Biol Endocrinol [Internet]. 2011 Feb 2 [cited 2022 Nov 14];9. Available from:

Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril [Internet]. 2016 Mar 1 [cited 2022 Nov 15];105(3):755-764.e8. Available from:

Halvaei I, Khalili MA, Razi MH, Nottola SA. The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles. J Assist Reprod Genet [Internet]. 2012 Aug [cited 2022 Oct 22];29(8):803. Available from: /pmc/articles/PMC3430773/

Maciej Serda, Becker FG, Cleary M, Team RM, Holtermann H, The D, et al. A preliminary profile of women opting for oocyte cryopreservation for non-medical reasons. G. Balint, Antala B, Carty C, Mabieme J-MA, Amar IB, Kaplanova A, editors. Hum Reprod [Internet]. 2010 [cited 2022 Nov 15];7(25 (supll 1)):14–7. Available from:

Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil Steril. 2013 Nov 1;100(5):1343-1349.e2.

Jones BP, Saso S, Mania A, Smith JR, Serhal P, Ben Nagi J. The dawn of a new ice age: social egg freezing. Acta Obstet Gynecol Scand [Internet]. 2018 Jun 1 [cited 2022 Nov 15];97(6):641–7. Available from:

Walker Z, Lanes A, Ginsburg E. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation. Reprod Biol Endocrinol [Internet]. 2022 Dec 1 [cited 2022 Nov 15];20(1):1–14. Available from:




How to Cite

Sirait, B., Handayani, N., Sundari, A. M., Wulandari, T. A., Sini, I., Polim, A. A., Rizal, M., & Boediono, A. (2022). The Utilization of Oocyte Cryopreservation Among Indonesia Women. Jurnal Profesi Medika : Jurnal Kedokteran Dan Kesehatan, 16(2).